Fig. 2From: A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2Similar to the results for ODI, a repeated-measures ANOVA indicated that the patients experienced a significant change in VAS (p < 0.001) but there was no difference in VAS when compared between groups. (p = 0.251)Back to article page